|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,427.00 GBX | +1.75% |
|
+0.32% | +6.16% |
| 06:08pm | Britain's life sciences plan gets mixed reception from pharma industry | RE |
| 15/07 | FTSE 100 retreats from record high as tariff worries resurface | RE |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility (Composite) | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 18 | ||||||||
| 27 | ||||||||
| 23 | ||||||||
| 27 | ||||||||
| 21 | ||||||||
| 19 | ||||||||
| 18 | ||||||||
| 19 | ||||||||
| 24 | ||||||||
| 28 | ||||||||
| 23 | ||||||||
| 26 | ||||||||
| 28 | ||||||||
| 22 | ||||||||
| 22 | ||||||||
| 14 | ||||||||
| - | 2 | |||||||
| 17 | ||||||||
| 16 | ||||||||
| Average | 21 | |||||||
| Weighted average by Cap. | 23 |
- Stock Market
- Equities
- GSK Stock
- Sector GSK plc
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition